The SRP72 gene helps move certain newly made proteins to the right place inside cells, which many tissues need to work normally. If this process does not work well, cells in the bone marrow may struggle to make healthy blood cells. Pathogenic variants in the SRP72 gene are linked to inherited bone marrow failure, including low blood counts, aplastic anemia, and in some families myelodysplastic syndrome. This gene is mainly known in clinical genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes hold the information needed to make proteins, the parts of cells that do the work. Others mainly control when certain processes happen, where they happen, and how strongly they run. Taken together, genes influence how the body develops and functions, and they can also shape how you respond to food, stress, or medications. More detailed information on this topic is available in the LearnHub.
Overview
SRP72Gene function
What if the gene works
The SRP72 gene helps cells guide newly made proteins to the right place, especially to a cell compartment that processes many proteins. This supports normal protein handling and everyday cell function.
Risk
What if the gene does not work
Variants in the SRP72 gene can cause inherited bone marrow failure, including low blood counts, aplastic anemia, or myelodysplastic syndrome. Some people also have hearing loss. Milder and more severe variants can influence when symptoms appear and how pronounced they are.
Treatment
What does that mean for your treatment
No SRP72-specific treatment or management approach is currently established; care is based on the person’s clinical findings, and drug choices are not guided by a pathogenic variant in the SRP72 gene itself.
Conditions associated with SRP72
Gene function
What if the gene works
Your cells rely on the SRP72 gene to help certain new proteins reach the right place at the right time. This supports the normal flow of proteins that are released from cells or built into cell membranes. This is part of how the SRP72 gene helps newly made proteins reach the endoplasmic reticulum (the cell area that processes many proteins).
The SRP72 gene helps direct certain newly made proteins to the endoplasmic reticulum, the cell area that folds and prepares many proteins. This is especially important for proteins that will be released from the cell or placed in the cell membrane.
As one of these proteins begins to form, the SRP72 protein helps the cell briefly pause protein building until the ribosome (the cell's protein making machine) reaches the endoplasmic reticulum. This keeps the handoff to the cell's protein processing pathway orderly.
The protein made from the SRP72 gene is one part of the signal recognition particle, a small helper complex made of proteins and a small RNA molecule (a working copy of genetic information). It helps this complex recognize delivery signals on growing proteins and link the ribosome to the right membrane.
What is a variant?
Genetic variants are small differences in a gene’s DNA sequence. They are common and help explain normal variation among people, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or directly cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the SRP72 gene reduce or disrupt the SRP72 protein, and how SRP72 gene variants affect protein function often depends on where the DNA change occurs. Milder variants may partly weaken the protein or its ability to join the signal recognition particle (a cell complex that guides newly made proteins), while more severe variants can shorten the protein or make it unstable so it cannot work normally. These larger functional losses can lead to earlier or more pronounced features in people with SRP72-related conditions.
How variants are linked to conditions
Rare pathogenic variants in the SRP72 gene can cause an inherited bone marrow failure condition. In affected families, SRP72 gene variants linked to aplastic anemia are the clearest finding, and some people also develop myelodysplastic syndrome and, less often, leukemia. The pattern is rare, and symptoms can vary between relatives.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are found widely across the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a potential link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SRP72 gene. For many living with an SRP72 change, risk appears to depend mostly on the specific variant and family history, so personal guidance from a doctor or genetic counselor can be helpful.
Inheritance of SRP72 variants
The inheritance pattern for SRP72-related bone marrow failure is usually autosomal dominant. This means a person with a disease-causing variant in one copy of the SRP72 gene can pass it to a child, and each pregnancy carries a 50% chance of inheriting that variant. Mothers and fathers can both pass it on, and sons and daughters can inherit it. Not everyone who inherits an SRP72 gene variant is affected in exactly the same way.
What does my SRP72 result mean for my family?
For SRP72, the family pattern that is best established is dominant, which means close relatives such as a parent, brother, sister, or child may also carry the same gene change. In families with an SRP72-related condition, relatives can be healthy, mildly affected, or more clearly affected, so the impact can vary from person to person. This is why a result in one family member can matter for others as well.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the SRP72 gene usually uses a blood or saliva sample. In genetic testing for SRP72 variants, a lab reads the gene's DNA sequence to look for changes and may also check for missing or extra pieces; results may show a disease-causing variant, a harmless variant, or a variant whose meaning is still unclear.
When should I consider getting a genetic test?
Consider SRP72 testing if you or close relatives have unexplained bone marrow failure, very low blood counts, aplastic anemia, or myelodysplastic syndrome, especially at a young age or in more than one family member. It can help show whether an inherited SRP72 change is part of the cause.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the blood, or responds to it at its target. This is common and helps explain why the same medication may work well for one person but less well for another, or why some people are more sensitive to side effects. These genetic differences are one part of the picture, along with age, kidney and liver function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences shape a person’s response to medicines. It studies links between genes and medications to help explain why the same treatment can affect people differently. With many drugs, genes influence both how much effect a medicine has and how the body handles it. This information can support treatment choices that are more informed and more personalized. To explore this subject further, more information is available in the LearnHub.
Drugs influenced by the SRP72 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so general questions about treatments, side effects, or medication changes are best discussed with your doctor. If something feels off after starting a medicine, your doctor can review your symptoms, other drugs, and overall health.
History
SRP72 entered medical genetics through research on the signal recognition particle, a cell system worked out over several decades in basic biology laboratories. Initially understood only through visible traits, later recognized as tied to a specific gene, SRP72 was identified as the gene for a 72 kilodalton protein within that particle. From these first observations, research expanded steadily as scientists mapped the gene and described its sequence in more detail. Interest in the SRP72 gene grew further when rare inherited variants were linked to bone marrow conditions, including families with low blood cell counts. These studies moved SRP72 from a laboratory finding to a gene with clear clinical relevance.